Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Interferon alfa-2b may interfere with the growth of cancer cells.
PURPOSE: Randomized phase III trial to study the effectiveness of interferon alfa-2b in
treating patients who have melanoma with early lymph node metastasis.